PRICE T ROWE ASSOCIATES INC /MD/ - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 214 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$59
+59.5%
150,000
+84.0%
0.00%
Q2 2023$37
-64.4%
81,500
-35.4%
0.00%
Q1 2023$104
-30.2%
126,165
+32.0%
0.00%
Q4 2022$149
-99.9%
95,599
-20.0%
0.00%
Q3 2022$207,000
-6.8%
119,472
-7.0%
0.00%
Q2 2022$222,000
-50.8%
128,484
+2.3%
0.00%
Q1 2022$451,000
-21.4%
125,606
+9.2%
0.00%
Q4 2021$574,000
-51.1%
115,042
-29.8%
0.00%
Q3 2021$1,173,000
-18.5%
163,792
+5.5%
0.00%
Q2 2021$1,440,000
+6.4%
155,292
+6.5%
0.00%
Q1 2021$1,353,000
-2.6%
145,815
-7.1%
0.00%
Q4 2020$1,389,000
+41.4%
156,984
+85.4%
0.00%
Q3 2020$982,000
-41.9%
84,677
+35.1%
0.00%
Q2 2020$1,689,000
+448.4%
62,672
+51.5%
0.00%
Q1 2020$308,000
+404.9%
41,360
+125.6%
0.00%
Q4 2019$61,000
+103.3%
18,334
+25.2%
0.00%
Q3 2019$30,000
-25.0%
14,641
+6.8%
0.00%
Q2 2019$40,000
-21.6%
13,7120.0%0.00%
Q1 2019$51,000
-5.6%
13,712
+0.7%
0.00%
Q4 2018$54,000
-28.0%
13,612
+1.2%
0.00%
Q3 2018$75,000
+47.1%
13,448
+3.9%
0.00%
Q2 2018$51,000
-16.4%
12,947
+0.7%
0.00%
Q1 2018$61,000
+45.2%
12,859
+26.1%
0.00%
Q4 2017$42,000
-35.4%
10,2000.0%0.00%
Q3 2017$65,000
-18.8%
10,2000.0%0.00%
Q2 2017$80,000
+17.6%
10,2000.0%0.00%
Q1 2017$68,00010,2000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
Renaissance Technologies 4,889,500$1,9020.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders